NFNoboru Fujise

Noboru Fujise

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Noboru Fujise has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Serum Mac‐2 Binding Protein Glycan Isomer and Cerebral White Matter Injury in Older Adults: A Hepatic–Cerebral Link

    by Maiko Nagaoka, Katsuya Nagaoka, Naoto Kajitani, Yoko Yoshimaru, Takehisa Watanabe, Hiroko Setoyama, Hirofumi Soejima, Noboru Fujise, Minoru Takebayashi, Manabu Makinodan, et al.

    Background and Aims: Metabolic dysfunction–associated steatotic liver disease (MASLD) is increasingly recognized as a systemic condition with extrahepatic complications; however, its impact on cerebral microvascular pathology remains poorly understood. This study aimed to examine the association between serum Mac‐2 binding protein glycan isomer (M2BPGi), a validated biomarker of liver fibrosis, and cerebral small vessel disease (CSVD), as reflected by T1‐weighted white matter hypointensity volume (WM hypointensity). Methods: We conducted a cross‐sectional analysis of 1577 community‐dwelling older adults enrolled in the Arao cohort, of whom 602 participants met the inclusion criteria and were included in the final analysis. MASLD was defined using the fatty liver index (FLI) ≥ 30 in combination with metabolic criteria. WM hypointensity volume was quantified using MRI and analyzed with FreeSurfer software. Multivariable linear regression analyses were performed to identify factors associated with WM hypointensity, adjusting for age, sex, and established vascular risk factors. Results: Higher serum M2BPGi levels were independently associated with increased WM hypointensity ( β = 1190.39, 95% CI 149.15–2231.63; p = 0.025) after adjustment for age, sex, hypertension, diabetes mellitus, hyperlipidemia, and high‐sensitivity C‐reactive protein. The association between M2BPGi and WM hypointensity was consistent regardless of MASLD status. Conclusions: Serum M2BPGi levels are independently associated with greater WM hypointensity burden in older adults, irrespective of MASLD status or systemic inflammation. These findings support the presence of a hepatic–cerebral axis and suggest that liver fibrosis biomarkers may help identify individuals at increased risk of cerebral microvascular injury.

  • Open Access

    Development of a calorie-based weight prediction equation for Anorexia nervosa: a case report

    by Riito Fujimoto, Naohiro Arai, Tomoyuki Imai, Yuta Oshima, Minoru Takebayashi, Shuken Boku, Noboru Fujise

    Background: Anorexia nervosa (AN) often requires nutritional rehabilitation including nasogastric feeding. However, achieving shared treatment goals between clinicians, patients, and families can be challenging. Weight prediction can be a valuable tool in this process; however, conventional approaches rely largely on clinical experience and lack precision. We therefore developed a simplified calorie-based weight prediction model grounded in the revised Harris–Benedict equation. Case presentation: This case report describes the clinical application of this model in a woman in her twenties with AN. By visualizing predicted weight trajectories under different caloric intake strategies, the model facilitated consensus building between the patient, her family, and the treatment team, leading to the acceptance of nasogastric feeding and structured behavioral therapy. Conclusions: The present case may suggest the potential utility of a calorie-based weight prediction model as a dynamic, noninvasive, and quantitative tool for inpatient management of AN. While the approach could facilitate understanding and agreement regarding treatment for AN, further evaluation in larger cohorts is required to assess accuracy and clinical impact.

  • The trajectory of non‐depressed suicidal ideation in community‐dwelling older people in a rural area in Japan: a prospective longitudinal study with a 3‐year follow‐up

    by Takahiro Ichiki, Asuka Koyama, Masaki Imai, Yoshitomo Nishi, Yasuhisa Abe, Ryuta Fukunaga, Ryoji Murakami, Maiko Nagaoka, Minoru Takebayashi, Noboru Fujise

    BackgroundSuicidal ideation is closely related to severe suicidal behaviour and is an important predictor of suicide attempt and completion, including in older people. Older people tend to have many opportunities to be conscious of death, and may have vague suicidal ideation because of various loss experiences, even if they are not depressed. We hypothesised that suicidal ideation among older people might be a risk factor for later transition to depression. The present study aimed to clarify risk factors that predict the incidence of depression in older people 3 years post-baseline in a rural area of Japan, and to examine the subsequent course of depression among non-depressed older people with suicidal ideation. MethodsIn 2015 and 2018, survey questionnaires were mailed to residents aged 65 years and over living in a rural area in Japan. Participants were divided into a depression group and a non-depression group using 15-item Geriatric Depression Scale scores 3 years post-baseline. Logistic regression analysis was used to identify predictive factors of late-life depression 3 years post-baseline. ResultsWe received 597 valid responses, with a 3-year follow-up rate of 78.8%. Regarding suicidal ideation, 6.7% of non-depressed older people exhibited suicidal ideation at baseline. Of these, 9.8% exhibited depression after 3 years post-baseline. Logistic regression analysis indicated that development of late-life depression is significantly associated with suicidal ideation, being female, and poor health-related quality of life (HRQOL). ConclusionsThe results revealed that suicidal ideation, being female, and poor HRQOL were predictive factors of the development of late-life depression 3 years post-baseline in a rural area of Japan. These findings provide novel information regarding the transition to depression among community-dwelling older people who are not depressed but have suicidal ideation. Whereas suicidal ideation is considered to be a symptom of depression, the current results suggest that suicidal ideation may precede depression in some older people.


  • Open Access

    How university students changed their habits and developed mental disorders in the context of the coronavirus disease 2019 (COVID‐19) pandemic in Japan: Three case reports

    by Maiko Nagaoka, Hiroe Kubo, Kuniko Tashiro, Maiko Kinoshita, Hiroko Inoue, Hirofumi Soejima, Noboru Fujise

    Background: Since the COVID‐19 pandemic reached Japan in 2020, the country has faced an unprecedented increase in suicide rate and school refusal among adolescents, as well as increased rates of depression and anxiety among young people. However, the effects of the COVID‐19 pandemic on adolescents in terms of changes in habits, the development of mental disorders, social isolation, and suicidal ideation remain largely unclear.Case Presentation: We examined three cases of university students who changed their habits during the COVID‐19 pandemic and developed mental disorders. All three cases had similar habitual changes, experienced loneliness, and developed depression and circadian rhythm sleep–wake disorder. Their habitual changes were delayed sleep and wake times, delayed first mealtime, a tendency to eat before sleeping, decreased social contact, increased digital media usage, and a tendency to use digital media before going to bed. We established a model of increasing mental health difficulties, school refusal, and suicidal ideation during the COVID‐19 pandemic.Conclusion: This report suggests possible approaches for preventing a decline in mental health during the COVID‐19 pandemic among university students.

  • Guidelines for diagnosis and treatment of depression in older adults: A report from the Japanese Society of mood disorders

    by Hajime Baba, Shinsuke Kito, Kazutaka Nukariya, Minoru Takeshima, Noboru Fujise, Junichi Iga, Hidehiro Oshibuchi, Masahiko Kawano, Mahiko Kimura, Katsuyoshi Mizukami, et al.

    The Committee for Treatment Guidelines of Mood Disorders, Japanese Society of Mood Disorders, published a Japanese guideline for the treatment of late‐life depression in 2020. Based on that guideline, the present guideline was developed and revised to incorporate the suggestions of global experts and the latest published evidence. In the diagnosis of late‐life depression, it is important to carefully differentiate it from bipolar disorders, depressive states caused by physical and organic brain disease, drug effects, and dementia, and to determine the comorbidity between late‐life depression and dementia. It is necessary to fully understand the clinical characteristics and psychosocial background of late‐life depression, evaluate the patient's condition, and provide basic interventions based on these factors. Problem‐solving therapy, reminiscence therapy/life review therapy, and behavioral activation therapy, and other forms of psychotherapy can reduce depressive symptoms. In terms of pharmacotherapy, newer antidepressants or non‐tricyclic antidepressants are recommended for late‐life depression, and it is recommended that the efficacy of least the minimal effective dosage should first be determined. Switching antidepressants and aripiprazole augmentation can be used to treatment‐resistant therapy. Electroconvulsive therapy and repetitive transcranial magnetic stimulation have demonstrated usefulness for late‐life depression. Exercise therapy, high‐intensity light therapy, and diet therapy also show some effectiveness and are useful for late‐life depression. Continuation therapy should be maintained for at least 1 year after remission.


  • Open Access

    Effect of lamotrigine in the treatment of bipolar depression with psychotic features: a case report

    by Tomoko Kajiya, Hiroko Sugawara, Yusuke Kajio, Satoru Morieda, Hibiki Tanaka, Tadashi Jono, Noboru Fujise, Mamoru Hashimoto

    Major depressive episodes with psychotic features are more common in bipolar disorder than in major depressive disorder; however, there is little information on the optimal treatment for bipolar depression with psychotic features. The patient was a 69-year-old man. At the age of 66, he was admitted to the hospital for the treatment of bipolar depression with psychotic features. He was treated with a combination therapy of antipsychotics and antidepressants during long-term hospitalization. At the age of 69, he relapsed and was admitted to the hospital again. He was initially treated with olanzapine and lithium for the treatment of bipolar depression with psychotic features. He partially responded to the combination therapy, and psychomotor retardation and delusion of guilt disappeared; however, he developed psychomotor agitation and delusion of persecution, which was a mood-incongruent psychotic feature. Finally, he fully recovered with an additional dosage of lamotrigine, and had no experience of relapse after discontinuation of olanzapine. This case report implicates the utility of lamotrigine for bipolar depression with psychotic features, and further studies are needed to establish the optimal treatment.


  • Comparisons of prevalence and related factors of depression in middle-aged adults between urban and rural populations in Japan

    by Noboru Fujise, Yasuhisa Abe, Ryuta Fukunaga, Youichi Nakagawa, Yoshitomo Nishi, Asuka Koyama, Manabu Ikeda


  • Item non-response on self-reported depression screening questionnaire among community-dwelling elderly

    by Asuka Koyama, Ryuta Fukunaga, Yasuhisa Abe, Yoshitomo Nishi, Noboru Fujise, Manabu Ikeda


    • 1 October 2013
      • Vol. 71  (10) , 1798-803

    [Apathy].

    by Ryuta Fukunaga, Noboru Fujise, Manabu Ikeda

    Apathy includes aspontaneous, indifferent behavior, with loss of motor and affective drive. Apathy is related to the disruption, at various anatomical sites, of frontosubcortical pathways, such as anterior cingulate and bithalamic lesions. Apathy was frequently reported in patients with Alzheimer's disease, post-stroke, and frontotemporal dementia. It is very important to distinguish apathy from depression by the therapeutic view point.

    • 1 January 2012
      • Vol. 114  (3) , 276-82

    [The relationship between depression and dementia in elderly].

    by Noboru Fujise, Manabu Ikeda

    It has been noted the relationship between depression and dementia in elderly. The prevalence of depression in Alzheimer's disease (AD) was reported 20 to 30% in population-based study. Apathy was more frequently observed than depression among demented outpatients in our study. Whereas the apathy has been considered to be a kind of depression traditionally, it has been found that the apathy is distinct from depression recently. In our clinical practice, we frequently realize the close relationship between depression and dementia. It has been reported that risk of AD was 1.71 (odds ratio) in the history of depression more than 25 years ago, and interval between diagnoses of depression and AD was positively related to increased risk of developing AD, suggesting that rather than a prodrome, depression may be a risk factor for AD. Furthermore, Rotterdam Scan Study reported recently that the risk of AD increased to 3.76 in the history of pre-senile depression, while 2.34 in the history of senile depression. On the other hand, it is interesting but still controversial whether depression is associated with the conversion from mild cognitive impairment (MCI) into dementia. The underlying neuropathological condition that causes MCI or dementia might also cause depressive symptoms.